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1. Introduction 
Malignant transformation of cells resulting from enhanced proliferation, aberrant 
differentiation, and impaired ability to die is the prime reason for abnormal tissue growth, 
which can eventually turn into uncontrolled expansion and invasion, characteristic of cancer 
(Hanahan and Weinberg, 2011). Such transformation is often accompanied by changes in ion 
channel expression and, consequently, by abnormal progression of the cellular responses 
with which they are involved. The first important role ascribed to plasma membrane ion 
channels, over 60 years ago, was their participation in cellular electrogenesis and electrical 
excitability. However, numerous subsequent studies have firmly established the 
contribution of ion channels to virtually all basic cellular behaviors, including such crucial 
ones for maintaining tissue homeostasis as proliferation, differentiation, and apoptosis 
(Lang et al., 2005; Razik and Cidlowski, 2002; Schonherr, 2005). The major mechanisms via 
which ion channels contribute to these crucial processes include: providing the influx of 
essential signaling ions, regulating cell volume, and maintaining membrane potential. 
Malignant transformation of cells resulting from enhanced proliferation, aberrant 
differentiation, and impaired ability to due is the prime reason for abnormal tissue growth, 
which can eventually turn into uncontrolled expansion and invasion, characteristic of cancer 
(Chaffer and Weinberg, 2011). This review focuses on the aspects prostate tumour 
carcinogenesis influenced by various ion channels belonging to a large superfamily of 
Transient Receptor Potential (TRP) channels and how dysfunctions and/or misregulations 
of these channels may influence the development and progression of prostate cancer. 
2. TRP-channels and epithelial cell homeostasis  
Transient Receptor Potential (TRP) channels are a recently discovered superfamily of non-
selective cationic channels defined firstly as mechanoreceptors. They are predominantly 
expressed in epithelial tissues and carry a plethora of functions including but not limited to 
sensation of chemical, mechanical, and thermo stimuli (for review see (Clapham et al., 2001)).  
According to a growing number of articles, non-voltage dependent cationic channels of the 
Transient Receptor Potential (TRP) channel family are key players in ion homeostasis. All 
TRPs contain six putative transmembrane domains, which are thought to assemble as homo- 
or hetero-tetramers to form cation selective channels. All TRPs are cation channels, although 
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the permeability for different mono- and divalent cations varies greatly between isoforms. 
Based on amino acid homologies, the mammalian TRP channel superfamily can be divided 
into seven families. About thirty members of the TRP superfamily identified in mammals 
are classified in six different families: TRPC for «Canonical», TRPV for «Vanilloid», TRPM 
for «Melastatin», TRPML for «Mucolipins», TRPP for «Polycystins» and TRPA for «Ankirin 
transmembrane», and the TRPN (no mechanoreceptor potential C, or NOMPC). The 
characteristic feature of TRP channels is their ability to be activated by a wide range of 
chemical and mechanical stimuli. TRP channels are activated by a wide range of stimuli 
including intra- and extracellular messengers, chemical, mechanical and osmotic stress, and 
some probably by the filling state of intracellular Ca2+ stores (Clapham, 2003). As such, they 
can be envisioned as the polymodal molecular sensors of the cell.  
For instance, all channels of the TRPC family are activated by stimulation of receptors that 
activate different isoforms of PLC, i.e. PLCǃ after activation of G-protein coupled receptors 
(GPCRs), and PLCǄ after activation of receptor tyrosine kinases (RTKs) (Clapham, 2003).  
TRPCs have also been widely proposed to be regulated by the filling status of intracellular 
Ca2+ stores, and consequently to be the elusive molecular candidates for store-operated Ca2+ 
entry channels (SOCs) (Clapham et al., 2001). However, both store-depletion dependent and 
independent mechanisms have been suggested for all members of the TRPC family, and at 
variance with a physiological role as SOCs, there is evidence that TRPC1, TRP4/5 and 
TRPC3/6/7 can function as receptor-operated channels that are mostly insensitive to store 
depletion (Lintschinger et al., 2000; Nilius, 2004; Plant and Schaefer, 2003).  
At the same time TRPV1–4 are non-selective cation channels which are thermosensitive, 
although TRPV1 and 4, can also be activated by numerous other stimuli (Nilius et al., 2003). 
TRPV3, and to a lesser extend also TRPV2 and TRPV1, but not TRPV4, can be activated by 2-
aminoethoxydiphenyl borate (2-APB), which, in contrast, blocks some TRPC and TRPM 
channels (Hu et al., 2004). Other members as TRPV5 and TRPV6 are highly expressed in the 
kidney and intestine, respectively, where they form highly selective Ca2+ channels essential 
for Ca2+ reabsorption (Nijenhuis et al., 2003). 
TRPM channels exhibit highly varying permeability to Ca2+ and Mg2+, from Ca2+-
impermeable (TRPM4 and 5) to highly Ca2+ and Mg2+ permeable (TRPM6 and 7). In 
contrast to that of TRPCs and TRPVs, the TRPM sequence does not contain ankyrin repeats. 
TRPM channel has a vide pattern of expression in human body and many of them are also 
temperature sensitive (Clapham, 2003).  
The TRPML proteins are relative small (less than 600 residues), and have relatively low 
sequence homology to other TRP families. TRPML1 is widely expressed, and appears to 
reside in late endosomes/lysosomes (LaPlante et al., 2004). TRPML1-mediated control of 
lysosomal Ca2+ levels plays an important role in proper lysosome formation and recycling 
(Piper and Luzio, 2004). 
A significant body of evidence indicates that TRPP1 and TRPP2 are physically coupled and 
act as a signaling complex which is necessary for localization of TRPP2 to the plasma 
membrane (Hanaoka et al., 2000), and in which the association of TRPP1 and TRPP2 
suppresses the G-protein stimulating activity of TRPP1 as well as the constitutive channel 
activity of TRPP2 (Delmas et al., 2004). It should be noted that TRPP2 likely has roles 
independent of TRPP1, as TRPP2 expression and TRPP2-like activity has been detected in 
left ventricular myocytes in the absence of TRPP1 (Volk et al., 2003). 
The TRPA family currently comprises just one mammalian member, TRPA1, which has been 
shown to be expressed in in hair cells (Corey et al., 2004), and in DRG and TG neurons (Story 
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et al., 2003). TRPA1 exhibits intruiging gating promiscuity, and might be involved in pain 
perception, temperature sensing, and mechanosensation, e.g. hearing (Voets et al., 2005). 
This subfamily TRPN comprises a single member, found in C. elegans, Drosophila and zebra 
fish whereas the mammalian genome appears to lack the TRPN gene (Corey et al., 2004).  
A large number of TRP channel binding partners have recently been described, many of which 
have been assigned important roles in the regulation and function of TRP channels. All TRPs 
also contain consensus sites for direct phosphorylation by serine/threonine and tyrosine 
kinases, although the role of phosphorylation in channel function remains to be fully 
elucidated. Also, in addition to regulatory modes activating TRP channels resident in the 
plasma membrane, several TRPs appear to be constitutively open, and may be regulated by 
vesicular insertion (Bezzerides et al., 2004; Iwata et al., 2003). Most, but not all, of the TRP 
channels function as Ca2+ pathways, cause cell depolarization, and also form intracellular 
pathways for Ca2+ release from various intracellular stores, such as the endo- and 
sarcoplasmic reticulum, lysosomes, and endosomes  (Clapham et al., 2001). Beyond their 
sensory functions, they are broadly involved in diverse homeostatic functions. It is not 
surprising, therefore, that dysfunctions of these TRP channels are involved in the pathogenesis 
of several diseases (Tsavaler et al., 2001; Wissenbach et al., 2001). Many TRP channels have so 
far been described in the genitourinary tract (Peng et al., 2001b; Tsavaler et al., 2001) and more 
specifically in the prostate, where they are suggested to play a role in normal prostate 
physiology and prostate diseases, most importantly in prostate carcinogenesis. 
3. TRPM channels and their possible implication in prostate cancer initiation 
In 2009 a new TRPM channel, TRPM2, has been identified in prostate cancer cell lines (Zeng et 
al., 2010). TRPM2 encodes a non-selective cation-permeable ion channel and it has benn found 
that selectively knocking down TRPM2 with the small interfering RNA technique inhibited the 
growth of prostate cancer cells but not of non-cancerous cells. The subcellular localization of 
this protein is also remarkably different between cancerous and non-cancerous cells. In BPH-1 
(benign), TRPM2 protein is homogenously located near the plasma membrane and in the 
cytoplasm, whereas in the cancerous cells (PC-3 and DU-145), a significant amount of the 
TRPM2 protein is located in the nuclei in a clustered pattern (Zeng et al., 2010). 
TRPM4 levels were shown to be elevated in prostate cancer (Armisen et al., 2011). However, 
whether such changes in TRPM4 expression may be relevant to genesis or progression of 
prostate cancer remains unknown.  
The last member of this family TRPM8 channel has been firstly cloned in 2001 as a novel 
prostate-specific gene by screening a prostate cDNA library (Tsavaler et al., 2001). Later on, it 
was shown that TRPM8 encodes for a cold- and menthol-sensitive ion channel in trigeminal 
ganglion and dorsal root ganglion neurons (TGN and DRG) (Voets et al., 2007). Moreover, the 
mRNA levels in BPH and PCa appeared to be higher than in the normal prostate (Tsavaler et 
al., 2001). Several groups have studied the expression of TRPM8 in different PCa cell lines. In 
primary cultures of prostate epithelial cells, the density of the TRPM8 membrane current was 
increased in cancerous compared to normal cells (Bidaux et al., 2007). Moreover, RT-PCR 
analysis of these cells revealed an up-regulation of TRPM8 in PCa-derived cells (Bidaux et al., 
2007). Also in tumoral cell lines, such as LNCaP (“lymph node carcinoma of the prostate”, a 
widely used cell line derived from a supraclavicular lymph node metastasis expressing the 
androgen receptor [AR] (Horoszewicz et al., 1983)), TRPM8 was detected by RT-PCR (Tsavaler 
et al., 2001). Zhang and Barritt also suggested a functional role for TRPM8 in LNCaP cells, 
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since temperatures below 28°C or application of 100 μM menthol, which is sufficient for 
TRPM8 activation, led to an increase in [Ca2+]cyt (Zhang and Barritt, 2004). Regarding the 
localization of TRPM8 in LNCaP, Thebault et al. reported that TRPM8 was almost exclusively 
expressed in the endoplasmic reticulum (Thebault et al., 2005), whereas Mahieu et al. reported 
a mainly plasmamembrane localization of TRPM8 (Mahieu et al., 2007).  
Bidaux et al. reported that TRPM8 expression requires a functional AR. Transfection of the AR 
into PNT1A cells, which lack the expression of the AR in normal physiological conditions, 
induced the appearance of TRPM8 that could be reversed by incubation of siRNA-AR (Bidaux 
et al., 2005). Primary cultures of prostate epithelial cells expressed the AR, TRPM8, CK8, and 
CK18 after 12 days, but after 20 days, the cultured cells displayed a more basal epithelial 
phenotype, expressing CK5 and CK14, but not the AR and TRPM8 (Bidaux et al., 2007). 
Moreover, it seems that the AR regulates the membranic translocation of TRPM8, since TRPM8 
resides in the ER in the absence of the AR, and only appears in the plasmamembrane when the 
AR is expressed. The authors postulated the hypothesis of a shift of plasma membrane TRPM8 
in normal apical fully differentiated epithelial cells to endoplasmic reticulum TRPM8 in a 
metastatic PCa cell during prostate carcinogenesis (Bidaux et al., 2007). 
Several studies using quantitative RT-PCR revealed a significantly increased expression of 
TRPM8 mRNA in malignant prostate samples in comparison to nonmalignant tissue, 
suggesting that the level of TRPM8 in biopsy specimens could be used in the diagnosis of PCa 
(Fuessel et al., 2003). This elevation seemed to be statistically significant, unlike the relative 
transcript-level elevation of PSA mRNA (Fuessel et al., 2003). However, no clear correlation of 
TRPM8 expression with the pathological grade of PCa could be found (Kiessling et al., 2003). 
Moreover, Henshall et al. showed a strong correlation between the level of TRPM8 mRNA 
expression and disease relapse after radical prostatectomy, as loss of TRPM8 was associated 
with a significantly shorter time to PSA relapse-free survival (Henshall et al., 2003). 
4. TRPC channels in prostate cancer cell survival 
The first TRPC channel which has been described in the prostate was TRPC3. Using 
Northern blot analysis, the expression of this gene was described in the normal prostate 
(Zhu et al., 1996). On the other hand, a more extensive quantitative TRP expression study in 
human prostate samples revealed the abundant expression of TRPC1, TRPC4, and TRPC6, 
whereas TRPC3, TRPC5, and TRPC7 were hardly detected (Riccio et al., 2002). In addition to 
normal prostate, immunohistochemistry revealed expression of TRPC6 in BPH and, more 
importantly, a significant overexpression in PCa specimens. Higher pathological stages of 
PCa tended to have increased TRPC6 expression, but these differences were not statistically 
significant among pT2, pT3, and pT4 PCa (Yue et al., 2009). Human primary prostate 
epithelial cell cultures expressed TRPC1A, a TRPC1 splice variant, TRPC3, TRPC4 (and the 
splice variant TRPC4ǃ), and TRPC6 (and the splice variant TRPC6Ǆ) at the mRNA level 
(Thebault et al., 2006). In LNCaP, the presence of TRPC1, TRPC3, TRPC5, and TRPC7 was 
detected; TRPC6, however, seemed not to be present (Pigozzi et al., 2006). 
The functional role of TRPC channels in the prostate has been investigated in human 
primary prostate epithelial cell cultures, using antisense assays of TRPC1, TRPC3, TRPC4, 
and TRPC6 (Thebault et al., 2006). It was postulated that TRPC1 and TRPC4 were 
exclusively involved in ATP-stimulated, store-dependent Ca2+ entry (SOCE), whereas 
TRPC6 was the diacylglycerol-gated, channel mediating ǂ1-AR (ǂ1-adrenergic receptor) 
agonist–stimulated Ca2+ influx (store independent). Moreover, treatment of the cultures 
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with ǂ1-AR agonists enhanced cell proliferation, in contrast to ATP, which had an inhibitory 
effect. Therefore, authors concluded that TRPC6 is a crucial mediator of the proliferative 
effects of ǂ1-AR agonists. TRPC1 and TRPC4, on the other hand, are the major contributors 
of SOC activation in response to ATP (Thebault et al., 2006). In LNCaP, TRPC1 and TRPC3 
were overexpressed after prolonged intracellular Ca2+ store depletion due to the decreased 
levels of [Ca2+]cyt. LNCaP cells overexpressing TRPC1 and TRPC3 showed an increased 
[Ca2+]cyt response to ǂ-adrenergic stimulation, but SOCE entry remained unaffected. Thus, 
expression of TRPC1 and TRPC3 is not sufficient for SOC formation (Pigozzi et al., 2006), 
though the other authors have considered TRPC1 as the most likely molecular candidate for 
the formation of prostate-specific endogenous SOCs which could participate to enhanced 
proliferation and apoptosis resistance (Vanden Abeele et al., 2003). 
5. TRPV channels as a hallmark of advanced prostate cancer 
Vanilloid receptor subtype-1 (TRPV1), the founding member of the vanilloid receptor-like 
transient receptor potential channel family, is a non-selective cation channel that responds to 
noxious stimuli such as low pH, painful heat and irritants. It has been shown that the 
vanilloid TRPV1 receptor is expressed in the prostate epithelial cell lines PC-3 and LNCaP as 
well as in human prostate tissue (Sanchez et al., 2005). The contribution of the endogenously 
expressed TRPV1 channel to intracellular calcium concentration increase in the prostate cells 
showed that the addition of capsaicin, (R)-methanandamide and resiniferatoxin to prostate 
cells induced a dose-dependent increase in the intracellular calcium concentration that was 
reversed by the vanilloid TRPV1 receptor antagonist capsazepine. These results indicate that 
the vanilloid TRPV1 receptor is expressed and functionally active in human prostate cells 
(Sanchez et al., 2005). 
Capsaicin-treated PC-3 cells increased the synthesis and secretion of IL-6 which was abrogated 
by the transient receptor potential vanilloid receptor subtype 1 (TRPV1) antagonist 
capsazepine, as well as by inhibitors of PKC-ǂ, phosphoinositol-3 phosphate kinase (PI-3K), 
Akt and extracellular signal-regulated protein kinase (ERK) (Malagarie-Cazenave et al., 2011). 
Furthermore, incubation of PC-3 cells with an anti-TNF-ǂ antibody blocked the capsaicin-
induced IL-6 secretion. These results raise the possibility that capsaicin-mediated IL-6 increase 
in prostate cancer PC-3 cells is regulated at least in part by TNF-ǂ secretion and signaling 
pathway involving Akt, ERK and PKC-ǂ activation (Malagarie-Cazenave et al., 2011). 
The nonselective cationic channel transient receptor potential vanilloid 2 (TRPV2) is a 
distinctive feature of castration-resistant PCa (Monet et al., 2010). TRPV2 transcript levels 
were higher in patients with metastatic cancer (stage M1) compared with primary solid 
tumors (stages T2a and T2b). Introducing TRPV2 into androgen-dependent LNCaP cells 
enhanced cell migration along with expression of invasion markers matrix 
metalloproteinase (MMP) 9 and cathepsin B. Consistent with the likelihood that TRPV2 may 
affect cancer cell aggressiveness by influencing basal intracellular calcium levels, small 
interfering RNA-mediated silencing of TRPV2 reduced the growth and invasive properties 
of PC3 prostate tumors established in nude mice xenografts, and diminished expression of 
invasive enzymes MMP2, MMP9, and cathepsin B. These findings establish a role for TRPV2 
in PCa progression to the aggressive castration-resistant stage, prompting evaluation of 
TRPV2 as a potential prognostic marker and therapeutic target in the setting of advanced 
PCa (Monet et al., 2010). Though the physiological role, the mechanisms of activation, as 
well as the endogenous regulators for the non-selective cationic channel TRPV2 are not clear 
far. It was shown that endogenous lysophospholipids such as lysophosphatidylcholine 
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(LPC) and lysophosphatidylinositol (LPI) induce a calcium influx via TRPV2 channel 
(Monet et al., 2009). TRPV2-mediated calcium uptake stimulated by LPC and LPI occurred 
via Gq/Go-protein and phosphatidylinositol-3,4 kinase (PI3,4K) signalling. The activation of 
TRPV2 channel by LPC and LPI leads to an increase in the cell migration of the prostate 
cancer cell line PC3 (Monet et al., 2009).  
TRPV6, an epithelium TRP channel highly selective for Ca2+ in organs that reabsorb Ca2+, 
was originally cloned from rat duodenum as a Ca2+ transport protein (Wissenbach and 
Niemeyer, 2007). In 2001, using Northern blot and in situ hybridization, Wissenbach et al. 
described that TRPV6 was present in PCa tissue specimens and in lymph node metastasis, 
but not in BPH or in normal prostate. The most elevated levels of TRPV6 mRNA were found 
in high-grade, locally advanced (pT3a/b) prostate tumors, whereas no TRPV6 mRNA was 
detectable in low-grade PCa, suggesting that TRPV6 could be a promising prostate tumor 
marker (Wissenbach et al., 2001). The onset of PCa seemed to be independent of the TRPV6 
genotype (Kessler et al., 2009). In 2001, Peng et al. (Peng et al., 2001a) confirmed these results 
via in situ hybridization experiments, but claimed that TRPV6 was also expressed in normal 
epithelial cells, BPH tissue, and LNCaP cells. Interestingly, TRPV6 mRNA expression 
correlated significantly with the Gleason score and the pathological stage (TRPV6 was 
absent in normal prostate, BPH, and pT1a/b lesions, but appeared in higher pathological 
stages)(Fixemer et al., 2003). Androgen Regulation of TRPV6 Peng et al. suggested in 2001 
that TRPV6 expression was androgen controlled, showing that the administration of AR 
antagonists to LNCaP cells resulted in a twofold increase of TRPV6 mRNA levels, whereas 
adding dihydrotestosterone (DHT) decreased TRPV6 levels (Peng et al., 2001b). In contrast, 
TRPV6 mRNA expression studies revealed decreased TRPV6 expression levels in androgen-
deprived human prostates (Fixemer et al., 2003). Other authors found that the application of 
AR antagonists or DHT had no significant effects on TRPV6 expression in LNCaP cells at all 
(Lehen'kyi et al., 2007). siRNA knockdown of the AR, however, induced a significant 
decrease of TRPV6 expression. Moreover, it was suggested that TRPV6 was regulated by the 
AR in a ligand-independent manner and that the AR constituted an essential cofactor of 
TRPV6 gene transcription in LNCaP cells (Lehen'kyi et al., 2007).  
From the other side, it’s known that cell hyperpolarization will always increase the driving 
force for Ca2+ entry via Ca2+-permeable ion channels, such as TRPV6. Ca2+ entry via these 
channels depends on coactivation of the intermediate-conductance, calcium-activated, 
potassium channels (IKCa or according to the IUPHAR nomenclature KCa3.1 or SK41) 
(Alexander et al., 2007), which are expressed in LNCaP cells as well as in primary prostate 
epithelial cultures. Moreover, KCa3.1 seemed to be preferentially expressed in PCa tissue, 
leading to hyperpolarization of the plasma membrane, after which TRPV6 is opened and 
Ca2+ influx occurs. siRNA knockdown of KCa3.1 and blocking of KCa3.1 led to a decreased 
cell proliferation in LNCaP (Lallet-Daher et al., 2009). Role of TRPV6 in Prostate Authors 
suggested a role for TRPV6 in cell proliferation. TRPV6 increased the proliferation rate of 
HEK cells in a Ca2+-dependent manner. As TRPV6 slightly enhanced global resting 
[Ca2+]cyt, these small changes could indeed increase proliferation rate. This suggests a 
causal relationship between PCa progression and TRPV6 expression (Schwarz et al., 2006). 
Lehen'kyi et al. showed that silencing assays of TRPV6 in LNCaP led to a decreased number 
of viable cells. They suggested a role for TRPV6 in LNCaP proliferation by mediating Ca2+ 
entry, which is followed by the activation of Ca2+-dependent NFAT (“nuclear factor of 
activated T cells”, a nuclear transcription factor) signaling pathways. As such, TRPV6 
increased cell survival and induced apoptosis resistance (Lehen'kyi et al., 2007). 
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6. Conclusions 
TRP channels are multifunctional sensors of environmental factors in the form of physical 
and chemical stimuli. They are widely expressed in the central nerve system and peripheral 
cell types, and are involved in numerous fundamental cell functions. In accordance with 
this, an increasing number of important pathological conditions are now being linked to 
TRP dysfunction. Though several TRP channels have been identified in the human prostate 
using non- or semi-quantitative methods, no TRP channels have definite, clear roles in 
prostate physiology or carcinogenesis. The majority of the TRP expression studies in the 
human prostate have used random prostate tissue, whereas the prostate itself is an 
extremely heterogeneous organ. There is a definite need for more appropriate prostate 
epithelial cell models, such as primary cultures of prostate epithelial cells, but the latter 
should be more thoroughly characterized. Many aspects of the physiology and regulation of 
TRPs are, however, still elusive, especially for some of the novel TRP family members. It is 
to be expected that the further evaluation of the cellular functions, regulation, and binding 
partners of TRPs, and their genetic and molecular properties may have an enormous impact 
in human prostate pathopysiology and disease and will become an urgent priority in 
biomedical sciences.  
Finally, the use of some of TRP channels as cancer biomarkers has been proposed and for 
some of them (as TRPV2 and TRPV6) the role as potential pharmaceutical targets has been 
predicted. Nevertheless, further studies using in vivo models are needed to establish this 
TRP channels as potential pharmaceutical targets for the future interventions in the 
treatment of the early and the late prostate cancer stages. 
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